OptimizeRx Corporation (OPRX)
NASDAQ: OPRX · Real-Time Price · USD
11.49
-0.46 (-3.85%)
May 21, 2025, 1:33 PM - Market open
OptimizeRx Market Cap
OptimizeRx has a market cap or net worth of $212.51 million as of May 21, 2025. Its market cap has increased by 9.20% in one year.
Market Cap
212.51M
Enterprise Value
233.17M
1-Year Change
9.20%
Ranking
Category
Stock Price
$11.49
Market Cap Chart
Since June 22, 2018, OptimizeRx's market cap has increased from $34.20M to $212.51M, an increase of 521.37%. That is a compound annual growth rate of 30.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 19, 2025 | 225.60M | 152.07% |
| Dec 31, 2024 | 89.50M | -65.55% |
| Dec 29, 2023 | 259.80M | -9.85% |
| Dec 30, 2022 | 288.20M | -73.89% |
| Dec 31, 2021 | 1.10B | 134.43% |
| Dec 31, 2020 | 470.80M | 223.35% |
| Dec 31, 2019 | 145.60M | 10.47% |
| Dec 31, 2018 | 131.80M | 285.38% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 674.78B |
| Johnson & Johnson | 365.77B |
| AbbVie | 327.54B |
| UnitedHealth Group | 285.61B |
| Novo Nordisk | 282.81B |
| Abbott Laboratories | 235.37B |
| AstraZeneca | 214.95B |
| Novartis AG | 213.43B |